lundi , novembre 11 2019

Evadeô Pro

Middle East

P.O. Box 45526 Abu Dhabi, UAE
Hamdane Street
AlGhaith Tower
Phone: +971 (0)2.508.9095
Mobile: +971 (0)55.660.3238
E-mail: contact@evadeopro.com

Evadeô Pro


6 bis rue Denis Papin
94450 Limeil Brevannes – France
Phone: + 33 (0)1.45.10.18.04
Mobile: + 33 (0)7.66.12.97.17
E-mail: contact@evadeopro.fr

Your Health, Our motto !     The specialist in medical tourism and medical evacuation toward France

caroussel-evadeo-pro-885x350
7
4
3
2
5
Home / News / A new technology using radioactivity in France: PET/MRI to diagnose and treat cancer

A new technology using radioactivity in France: PET/MRI to diagnose and treat cancer

For the past two years, Henri-Mondor Hospital has been using an innovative machine, combining MRI and PET for more accurate cancer diagnosis.

Siemens medical’s TEP/IRM -Biograph mMR – installed at Henri Mondor Hospital is the first machine in France specifically dedicated to research in routine care and to optimizing the path of care in oncology. This integrated PET/IRM is the 4th hybrid imaging machine in France and the 2nd to be installed in one of the AP-HP hospitals, the first being installed at the Pitié Salpêtrière hospital.

More than 200 patients have already benefited from it because, in diagnostic, prognostic or therapeutic management, some cancer patients require both Magnetic Resonance Imaging (MRI, for the study of the tissue microenvironment in which tumours develop) and Positron Emission Tomography (PET, for the study of tumour metabolism and aggressiveness).
The PET-MRI is a device that combines information from different sources. It is a cutting-edge technology that has been able to meet technical challenges, in particular that of overcoming interference between equipment. Indeed, the high magnetic fields of the MRI must not disturb the photomultipliers and the electronics of the PET and vice versa. Due to better spatial resolution and contrast between tissues, it improves tissue characterization. During the same examination, it allows to study in a combined way, tissue perfusion, water molecule diffusion, microstructural organization and cellularity, with PET analysis of carbohydrate metabolism, perfusion, tissue anoxia or with the study of certain cellular populations.

The main cancers likely to be affected by the installation of this new device will be:

  • lymphomas
  • digestive cancers: liver cancer…
  • prostate cancer
  • breast cancer

EVADEO PRO in collaboration with these institutions equipped with this new technology: the principle of one-shot PET/MRI imaging will make it possible to personalize patient management through better characterization of cancers at diagnosis, better treatment orientation and better evaluation of therapeutic response, while providing patients with increased comfort and faster management.

EVADEO PRO supports you in the diagnosis and treatment of these pathologies and assists you in your care journey as part of a complete health check-up, during a medical evacuation or a medical stay for the treatment of these various diseases.

And because Evadeô Pro appears as the leader in medical tourism in France, we also offer you to enhance your stay by selecting among our services at a preferential price, those that correspond to your desires or your needs…

Ask to be called back, or contact us by phone or email to tell us your needs; our team will do the rest!

Evadêo Pro – Leader in healthcare stays and medical tourism in France.

Vérifiez également

Infantile congenital malformations

Birth defects (at birth) are not uncommon, accounting for an estimated 1 in 33 births ...